Recent findings suggest that post-COVID chronic cough may be driven by neurological factors, not just respiratory issues.

While unfortunately, the same state's Department of Health reports their flu rates have reportedly increased 90% week-over-week.

If your cold symptoms won't quit, you may have something else. Doctors explain what it could mean if you've got a lingering ...

Behavioral cough suppression therapy may be effective in patients with refractory and unexplained chronic cough (RCC and UCC).

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total ...

AURORA, CO / ACCESS Newswire / January 31, 2025 / Exxel Pharma ("Exxel" or the "Company"), a pharmaceutical company dedicated to developing novel therapeutics for the treatment of neuronal ...

There are no approved therapies for the treatment of chronic cough in IPF and current off-label treatment options provide minimal benefit to patients. Refractory chronic cough affects approximately ...

Unexpectedly, more than 40 adults have also contacted Weinberger to let him know that their chronic cough also resolved during or soon after viewing the video, even after some of them had dealt ...

“A cough is a reflex action which can cause a sudden noisy expulsion of air from the lungs,” says Claire Nevinson, Boots’ Superintendent Pharmacist. “The most common types of coughs are a ...

1 However, this approach has failed people with refractory or unexplained chronic cough who do not seem to have a primary cause for their cough and for whom treatment of associated conditions does not ...

Camlipixant (NEO-5937) is under development for the treatment of chronic refractory cough and and other cough hypersensitization-related disorders. The drug candidate is a benzoimidazole derivative, ...